Resultats globals: 2 registres trobats en 0.03 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
2 p, 188.6 KB Synthesis, in vitro profiling, and in vivo efficacy studies of a new family of multitarget antiAlzheimer compounds / Pérez-Areales, Francisco Javier (University of Barcelona) ; Garrido, María (Instituto de Química Avanzada de) ; Catalunya (IQAC-CSIC) ; Aso, Ester (University of Barcelona) ; Bartolini, Manuela (Department of Pharmacy and Biotechnology. Alma Mater Studiorum University of Bologna) ; De Simone, Angela (University of Bologna. Department for Life Quality Studies) ; Espargaró Colomé, Alba (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Ginex, Tiziana (University of Barcelona) ; Sabate, Raimon (University of Barcelona) ; Pérez, Belén (Autonomous University of Barcelona. Therapeutics and Toxicology) ; Andrisano, Vincenza (University of Bologna. Department for Life Quality Studies) ; Luque, Francisco Javier (University of Barcelona) ; Ferrer, Isidro (Universitat de Barcelona. Unitat de Neuropatologia Experimental) ; Ciruela, Francisco (University of Barcelona) ; Messeguer, Àngel (Instituto de Química Avanzada de) ; Catalunya (IQAC-CSIC) ; Muñoz Torrero, Diego (Universitat de Barcelona. Laboratori de Química Farmacèutica)
Simultaneous modulation of several targets or athological events with a key pathogenic role is a promising strategy to tackle thus far difficult-to-cure or incurable multifactorial diseases, such as Alzheimer's disease (AD). [...]
2019 - 10.3390/proceedings2019022071
Proceedings, Vol. 22 (2019) , p. 1-2  
2.
19 p, 3.9 MB Increasing polarity in tacrine and huprine derivatives : Potent anticholinesterase agents for the treatment of myasthenia gravis / Galdeano, Carles (Universitat de Barcelona. Laboratori de Química Farmaceutica) ; Coquelle, Nicolas (Large-Scale Structures Group. Institut Laue-Langevin) ; Cieslikiewicz-Bouet, Monika (Laboratory COBRA (UMR 6014). Normandie Université. UNIROUEN. Institut National des Sciences Appliquées (INSA) Rouen. CNRS) ; Bartolini, Manuela (Department of Pharmacy and Biotechnology. Alma Mater Studiorum University of Bologna) ; Pérez, Belen (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Clos, Victòria (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Silman, Israel (Department of Neurobiology. Weizmann Institute of Science) ; Jean, Ludovic (Laboratory COBRA (UMR 6014). Normandie Université. UNIROUEN. Institut National des Sciences Appliquées (INSA) Rouen. CNRS) ; Colletier, Jacques Phillippe (Institut de Biologie Structurale. Université Grenoble Alpes. Centre National de la Recherche Scientifique (CNRS). Commissariat à l'Énergie Atomique (CEA) (UMR 5075)) ; Renard, Pierre Yves (Laboratory COBRA (UMR 6014). Normandie Université. UNIROUEN. Institut National des Sciences Appliquées (INSA) Rouen. CNRS) ; Muñoz Torrero, Diego (Universitat de Barcelona. Laboratori de Química Farmaceutica)
Symptomatic treatment of myasthenia gravis is based on the use of peripherally-acting acetylcholinesterase (AChE) inhibitors that, in some cases, must be discontinued due to the occurrence of a number of side-effects. [...]
2018 - 10.3390/molecules23030634
Molecules, Vol. 23 Núm. 3 (2018) , p. 634  

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.